Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.380
+0.190 (8.68%)
At close: Jun 18, 2025, 4:00 PM
2.400
+0.020 (0.84%)
Pre-market: Jun 20, 2025, 8:47 AM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $329.11 million as of June 20, 2025. Its market cap has increased by 75.88% in one year.
Market Cap
329.11M
Enterprise Value
222.86M
1-Year Change
75.88%
Ranking
Category
Stock Price
$2.38
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $329.11M, a decrease of -24.40%. That is a compound annual growth rate of -6.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 329.11M | 64.97% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 710.32B |
| Johnson & Johnson | 366.64B |
| Novo Nordisk | 334.60B |
| AbbVie | 327.63B |
| UnitedHealth Group | 280.19B |
| Abbott Laboratories | 230.15B |
| Novartis AG | 229.92B |
| AstraZeneca | 223.18B |